Breaking News
October 18, 2018 - Using NMR to Reduce Fraud
October 18, 2018 - New automated model identifies dense breast tissue in mammograms
October 18, 2018 - Mysterious polio-like illness baffles medical experts while frightening parents
October 18, 2018 - Cases of Acute Flaccid Myelitis on the rise across U.S.
October 18, 2018 - Dietary fiber reduces brain inflammation during aging
October 18, 2018 - New tool could help prioritize recovery efforts for the poorest hit by natural disasters
October 18, 2018 - Hundreds of dietary supplements shown to contain unapproved drugs
October 18, 2018 - Active Pharmaceuticals ID’d in >700 Dietary Supplements
October 18, 2018 - Cell death protein also damps inflammation
October 18, 2018 - Health Highlights: Oct. 15, 2018
October 18, 2018 - Largest study of ‘post-treatment controllers’ reveals clues about HIV remission
October 18, 2018 - Bad Blood in Silicon Valley: A conversation with John Carreyrou
October 18, 2018 - ANTRUK’s Annual Lecture sends out message on shortage of funds for antibiotic research
October 18, 2018 - NAM special publication outlines steps to ensure interoperability of health care systems
October 18, 2018 - Novel method uses just a drop of blood to monitor effect of lung cancer therapy
October 18, 2018 - New blood test could spare cancer patients from unnecessary chemotherapy
October 18, 2018 - Training young researchers to work with data volumes arising in the health sector
October 18, 2018 - New Metrohm IC method is reliable and convenient to use for zinc oxide assay
October 18, 2018 - Global AIDS, TB fight needs more money: health fund
October 18, 2018 - Understanding the forces that cause sports concussions
October 18, 2018 - Research points to new target for treating periodontitis
October 18, 2018 - New tool improves assessment of postpartum depression symptoms
October 18, 2018 - From Biopsy to Diagnosis
October 18, 2018 - Sexual harassment and assault linked to worse physical/mental health among midlife women
October 18, 2018 - Stumped by medical school? A Q&A with a learning specialist
October 18, 2018 - Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation
October 18, 2018 - Study finds changes in antiepileptic drug metabolism during different trimesters of pregnancy
October 18, 2018 - Autonomic nervous system directly controls stem cell proliferation, study shows
October 18, 2018 - FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
October 18, 2018 - Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer
October 18, 2018 - Many U.S. adults confused about primary care, study shows
October 18, 2018 - UC researcher focuses on light-mediated therapies to target breast cancer
October 18, 2018 - With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center
October 18, 2018 - Mice study shows antibiotics are not always necessary to cure sepsis
October 18, 2018 - Researchers discover why heart contractions are weaker in individuals with HCM
October 18, 2018 - Participation in organized sport during childhood may have long-term skeletal benefits
October 18, 2018 - Probiotic/antibiotic combination could eradicate drug-resistant bacteria
October 17, 2018 - More Socioeconomic Challenges for Hispanic Women With HIV
October 17, 2018 - 49,XXXXY syndrome – Genetics Home Reference
October 17, 2018 - Scientists uncover possible new causes of Tourette syndrome
October 17, 2018 - Girl undergoes unusual heart surgery after compassionate-use exemption | News Center
October 17, 2018 - Health Issues That Are Sometimes Mistaken for Gluten Sensitivity
October 17, 2018 - Elective induction of labor at 39 weeks may be beneficial option for women and their babies
October 17, 2018 - New smart watch algorithms can accurately monitor wearers’ sleep patterns
October 17, 2018 - Researchers demonstrate epigenetic memory transmission via sperm
October 17, 2018 - FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices
October 17, 2018 - Health Tip: Know the Risks of Chicken Pox
October 17, 2018 - Immunotherapy effective against hereditary melanoma
October 17, 2018 - Researchers reveal new mechanism for how animal cells stay intact | News Center
October 17, 2018 - Alzheimer's Goes Under the Cryo-Electron Microscope
October 17, 2018 - Medicare for all? CMS chief warns program has enough problems already
October 17, 2018 - Metrohm Raman introduces Mira P handheld Raman system
October 17, 2018 - Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
October 17, 2018 - Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features
October 17, 2018 - Many healthy children may have metabolic risk factors, finds study
October 17, 2018 - A new antibiotic could be a better, faster treatment for tuberculosis
October 17, 2018 - “I will not become a Robot Doctor”: A medical student vows to practice compassion
October 17, 2018 - Study findings may explain sporadic outbreaks of C. difficile infections in hospitals
October 17, 2018 - Purdue researchers develop new chemical process to find better drug ‘fits’ for patients
October 17, 2018 - Yale researchers develop way to attack RNA with small-molecule drugs
October 17, 2018 - New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug
October 17, 2018 - Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
October 17, 2018 - Nine cases of polio-like illness suspected in children in illinois
October 17, 2018 - Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries
October 17, 2018 - Patients once thought incurable can benefit from high-dose radiation therapy
October 17, 2018 - Researchers awarded grant to advance testing of experimental heroin vaccine
October 17, 2018 - Researchers examine SSRI use during pregnancy and major gestational malformations
October 17, 2018 - FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T
October 17, 2018 - Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment
October 17, 2018 - Study reveals link between childhood abuse and higher arthritis risk in adulthood
October 17, 2018 - Research shows people over 65 are not performing enough physical activity
October 17, 2018 - FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
October 17, 2018 - Weight gain after smoking cessation linked to increased short-term diabetes risk
October 17, 2018 - Researchers find opportunity to control salt-sensitive hypertension without exercising
October 17, 2018 - Women not warned about cancer associated with breast implants
October 17, 2018 - Metrohm offers robust handheld Raman analyzer for Defense and Security
October 17, 2018 - Modeling Non-Numerical Data in Systems Biology
October 17, 2018 - Research aims to address health disparities in African-American men
October 17, 2018 - Human and cattle decoys trap outdoor-biting mosquitoes in malaria endemic regions
October 17, 2018 - High Circulating Prolactin Level Inversely Linked to T2DM Risk
Assessing health impact of new antimicrobials could encourage further drug development

Assessing health impact of new antimicrobials could encourage further drug development

image_pdfDownload PDFimage_print
Credit: CC0 Public Domain

In a new report, researchers at the University of York have investigated the ways in which the value of new antimicrobial drugs could be assessed to help the NHS decide how much should be paid for them.

Commissioned by the Department of Health and Social Care and funded by the National Institute for Health Research (NIHR), the report aims to demonstrate how new drugs could be assessed based on their value to the NHS. Having such a system in place could help to incentivise manufacturers to produce more new antimicrobials.

Antimicrobial resistance (AMR) is a major global health concern, as infectious organisms become increasingly resistant to a range of antimicrobials. Pharmaceutical and biotechnology industries, however, are becoming reluctant to develop new drugs citing limited return on investment.

Pressing issue

Chief Medical Officer for England, Professor Dame Sally Davies, said:”It is no exaggeration to say antimicrobial resistance is among the most pressing issues we face globally.

“Finding ways to incentivise companies to develop new drugs is a vital component of our response to this escalating threat.

“Ensuring the NHS pays a fair price for new antimicrobials whilst conserving their use is essential and this report provides a platform to deliver this.”

International action

The Lord O’Neill Independent Review on AMR had previously recommended that countries should support international action through better national purchasing arrangements of antimicrobial drugs.

This new study informs the various ways that the NHS could pay for new antibiotic drugs, by making recommendations to the National Institute for Health and Care Excellence (NICE) on how to consider the appraisal of new antimicrobials.

Currently a conventional payment method is employed to fund new antimicrobials, which is based on how much of the drug the NHS uses. Some new antimicrobials are held in reserve for use only when existing products are ineffective due to resistance, but this strategy limits revenues to manufacturers reducing the attractiveness of developing new antimicrobials.

‘Delinked’ payment

The government is therefore considering a novel payment approach where the NHS pays for access to the drug; this means that payment is ‘delinked’ from the amount of the drug that is actually used. Establishing appropriate levels of payment, however, is complex.

Mark Sculpher, Professor of Health Economics at the University of York, said: “NICE plays an important role in using evidence to guide the NHS about the effectiveness and value for money of new pharmaceuticals.

“Given the priority associated with having new antimicrobial agents available with increasing drug resistance, any role for NICE in appraising these products needs to involve the most appropriate methods, evidence and process.

“Our latest report looks at how NICE could appraise the benefits of these new drugs so that the NHS can make informed decisions on sustainable funding.”

Evidence

The report recommends that, under a delinked payment system, NICE should use the available evidence to estimate the long-term impact on the health of the population based on the availability of a new antimicrobial.

This can provide more evidence to inform sustainable funding, which also takes into consideration the health benefits that could be produced if those resources were devoted to other NHS activities.

Professor Sculpher said: “Having new drugs available to treat infectious disease is a major priority internationally given the challenge of resistance. But the NHS has to be able to agree funding with the manufacturers of new products based on information about the benefits they are expected to confer on patients over many years.

“Estimating this impact is extremely difficult when the drugs become first available, as relevant evidence is limited. It is essential for the NHS to collect surveillance data on how drugs are used, their outcomes and changes in resistance.”

Public health

The report states that levels of funding by the NHS under ‘delinked’ arrangements cannot be set in stone permanently. Rather, they should be revisited as new evidence becomes available and estimates of population health impact are revised.

Meindert Boysen, Director of the NICE Centre for Health Technology Evaluation, said: “The report provides invaluable insights in to the issues and complexity of capturing the full public health value of new antimicrobials. We will continue to work with partners and stakeholders on how the recommendations could translate to a pragmatic value framework and payment model for new antimicrobials.”


Explore further:
FDA researchers report first evidence of ESBL producing E. Coli in US retail meat

Provided by:
University of York

Tagged with:

About author

Related Articles